Literature DB >> 7574674

Active-site topology of bovine cholesterol side-chain cleavage cytochrome P450 (P450scc) and evidence for interaction of tyrosine 94 with the side chain of cholesterol.

I A Pikuleva1, R L Mackman, N Kagawa, M R Waterman, P R Ortiz de Montellano.   

Abstract

Combining site-directed mutagenesis with analysis of the active-site topology of bovine cholesterol side-chain cleavage cytochrome P450scc (P450scc), we have investigated the roles of tyrosine residues 93 and 94 on substrate binding. Four single mutants (Y93A, Y93S, Y94A, and Y94S) and one double mutant (Y93S/Y94S) were examined. The largest increase in Ks was observed for binding of cholesterol and 25-hydroxycholesterol to the Y94S mutant (approximately 5.5-fold), with a smaller increase (< 2.5-fold) for binding of 22-hydroxycholesterol. Mutation of Y94 thus appears to influence the interaction with cholesterol, 25-hydroxycholesterol, and possibly 22-hydroxycholesterol. Y93 is not involved in binding of 22- and 25-hydroxycholesterol but may interact with cholesterol. The active-site topologies of P450scc and its mutants were probed by reaction with three arylhydrazines. The N-arylprotoporphyrin IX regioisomer patterns obtained with phenyl- and 2-naphthylhydrazine indicate that the active site is primarily open above pyrrole ring A and suggest that a region some distance above pyrrole ring D is also open. The single mutations Y93S, Y93A, Y94A, and Y94S do not detectably alter the regioisomer patterns obtained with the phenyl- and 2-naphthyl probes, but a small, reproducible change is observed with the 2-naphthyl probe for the Y93S/Y94S double mutant. The conformational alteration implied by this change could not be detected by titration with 22- and 25-hydroxycholesterol but is detectable by titration with cholesterol. The results indicate that cholesterol binds over pyrrole ring D of the heme in bovine P450scc, strongly suggest that Y94 interacts with the side chain of cholesterol, and provide evidence that the side chains of 22- and 25-hydroxycholesterol bind to a different region of the active site than the side chain of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574674     DOI: 10.1006/abbi.1995.1451

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis.

Authors:  Andrew Midzak; Nagaraju Akula; Laurent Lecanu; Vassilios Papadopoulos
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

2.  Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1.

Authors:  Natalia Mast; Andrew J Annalora; David T Lodowski; Krzysztof Palczewski; C David Stout; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2010-12-15       Impact factor: 5.157

3.  Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.

Authors:  Kirsty J McLean; Nigel S Scrutton; Andrew W Munro
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

4.  Studies of membrane topology of mitochondrial cholesterol hydroxylases CYPs 27A1 and 11A1.

Authors:  Irina A Pikuleva; Natalia Mast; Wei-Li Liao; Illarion V Turko
Journal:  Lipids       Date:  2008-09-13       Impact factor: 1.880

5.  Inhibition and stimulation of activity of purified recombinant CYP11A1 by therapeutic agents.

Authors:  Natalia Mast; Marlin Linger; Irina A Pikuleva
Journal:  Mol Cell Endocrinol       Date:  2012-10-23       Impact factor: 4.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.